Vaccination may combat Clostridium difficile

UK - Whilst the life-threatening Clostridium difficile is not absolutely resistant to antibiotics, after an individual has been infected the bacteria often reappears.

Photo: Vaccination may combat Clostridium difficile

Vaccination against it is therefore seen as the possible answer, and now results from initial trials of one made by Acambis, a Cambridge-based biotech company, have encouraged its scientists to discuss involvement of the National Health Service (NHS) in tests in hospitals this year.
Rather than targeting the infection, this developing vaccine focuses on the toxins produced by a C. difficile infection. Trials on 200 patients indicate that the vaccine was effective at combating one of the major toxins in 100% of cases and a second major toxin in 75% of cases.
It is hoped that a course of three injections will provide long-lasting protection for over a decade.

01.03.2008

More on the subject:

Related articles

Photo

News • Infection control

Study highlights transmission risk of resistant bacteria in hospital sinks

A new study identifies hospital sinks as a source of bacterial outbreaks, highlighting the vulnerability for contamination. The researchers also point out the difficulties in stopping such outbreaks.

Photo

News • Study on gentle cleansers

Virus-killing properties of soaps: No need for the 'hard stuff'

Gentle cleansers are just as effective in killing viruses – including coronavirus – as harsh soaps, according to a new study from scientists at the University of Sheffield.

Photo

Sponsored • Gastrointestinal endoscopy

Innovating products that balance patient safety and environmental concerns

As transparency surrounding the eco-footprint of hospitals becomes more important, medical device manufacturers must recognize the need for action to tackle global challenges, such as climate change.

Related products

Subscribe to Newsletter